Rifampicin-induced acute tubulointerstitial nephritis during pulmonary tuberculosis treatment: A case report.
Chirine MoussaSamia EsbaaHouda RouisNada SellamiMeriam HajjiYoldez HoucineAmel KhattabIbtihel KhouajaInes ZendahSonia MaâlejPublished in: Respirology case reports (2023)
Drug-induced tubulointerstitial nephritis is an uncommon complication in patients on anti-tuberculosis therapy that can lead to permanent kidney damage. Rifampicin is the most offending drug. We report a case of a 41-years old man being treated for pulmonary tuberculosis and presenting with tubulointerstitial nephritis associated with rifampicin. We focus on diagnosis features and therapeutic challenges.
Keyphrases
- pulmonary tuberculosis
- drug induced
- mycobacterium tuberculosis
- liver injury
- end stage renal disease
- newly diagnosed
- ejection fraction
- oxidative stress
- prognostic factors
- adverse drug
- peritoneal dialysis
- stem cells
- emergency department
- patient reported outcomes
- bone marrow
- human immunodeficiency virus
- patient reported